Urology News and Research

Latest Urology News and Research

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.

16 Mar 2013

Novel therapeutic strategy for post-prostatectomy erectile dysfunction

Transplantation of mesenchymal stem cells cultivated on the surface of nanofibrous meshes could be a novel therapeutic strategy against post-prostatectomy erectile dysfunction, conclude the authors of a study which is to be presented at the 28th Annual EAU Congress later this week.

16 Mar 2013

ConservoCare obtains license options to develop nerve-block medical device for bladder control

ConservoCare, LLC, a spinoff of research at Case Western Reserve University, has obtained license options through the university's Technology Transfer Office to develop a medical device for bladder control.

16 Mar 2013

Study: Flagellin plays a critical role in regulating host innate defences against UTIs

A new study by British scientists reveals that motile Escherichia coli isolates demonstrated significant activation of NF-κB signaling suggesting that flagellin plays a key role in up-regulating the host innate defences against urinary tract infections (UTIs).

15 Mar 2013

Previously unknown cell discovered in the urethra of mice

A recent study conducted by a group of German scientists revealed the presence of a previously unknown cell in the urethra of mice. These chemosensory cholinergic brush cells are in close contact to sensory neurons that express cholinergic receptors.

15 Mar 2013

Study reveals impact of physician financial incentives and highlights importance of patient education

According to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, prostate cancer patients of urologists who own expensive radiation equipment are more likely to receive radiation treatment in lieu of surgery than patients treated by urologists without an ownership stake in the equipment.

13 Mar 2013

Research: Stringent criteria for surveillance of prostate cancer needed for African Americans

New research from The Cancer Institute of New Jersey suggests that more stringent criteria may be needed for African American men with prostate cancer when considering active surveillance of the disease.

11 Mar 2013

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

In Africa and Thailand, communities that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study presented this week at the Conference on Retroviruses and Opportunistic Infections in Atlanta.

6 Mar 2013

Financial, cultural and communication barriers play a major role in prostate cancer care

A combination of financial, cultural and communication barriers plays a role in preventing underserved Latino men with prostate cancer from accessing the care and treatment they need, according to a new study by researchers at the UCLA School of Nursing.

6 Mar 2013

Androgen deprivation therapy interferes with diabetes control

Androgen deprivation therapy for prostate cancer hampers glycemic control in men with diabetes, report researchers.

5 Mar 2013

Mirabegron reduces frequency of incontinence episodes in phase III trial

In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder compared to those in a placebo group.

5 Mar 2013

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate.

28 Feb 2013

Follow up evaluations necessary for 15 years after radiation therapy for prostate cancer patients

27 Feb 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI)) to the Japanese Ministry of Health, Labor and Welfare.

27 Feb 2013

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Actavis, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone.

26 Feb 2013

Screening of children with LUT dysfunction needs refining

Physicians should include screening for psychosocial comorbidities and obesity when evaluating children with lower urinary tract dysfunction, say researchers.

25 Feb 2013

Greek and Spanish patients can now read EAU Patient Information in their native language

Greek and Spanish-speaking patients with kidney or ureteral stones can now read EAU Patient Information in their native language. The Endourology, Laparoscopy and Urotechnology Section of the Hellenic Urologic Association (HUA) has provided the Greek translation and the Spanish translation is the result of a collaboration between the Spanish Association of Urology (AEU) and the Dominican Republic Society of Urology (SDU).

25 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

GCP could help lengthen life expectancy of certain prostate cancer patients

A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.

21 Feb 2013

Predictive value of prostate cancer gene 3 validated

Researchers have confirmed that the prostate cancer gene 3 is a valid predictor for current cancer and future biopsy outcomes.

20 Feb 2013

Urology News and Research

Latest Urology News and Research

Genetic score based on PCa risk-associated SNPs predicts prostate biopsy outcomes: Study

Novel therapeutic strategy for post-prostatectomy erectile dysfunction

ConservoCare obtains license options to develop nerve-block medical device for bladder control

Study: Flagellin plays a critical role in regulating host innate defences against UTIs

Previously unknown cell discovered in the urethra of mice

Study reveals impact of physician financial incentives and highlights importance of patient education

Research: Stringent criteria for surveillance of prostate cancer needed for African Americans

Study shows community-based HIV-prevention efforts increase testing rates, reduce HIV incidence

Financial, cultural and communication barriers play a major role in prostate cancer care

Androgen deprivation therapy interferes with diabetes control

Mirabegron reduces frequency of incontinence episodes in phase III trial

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

Follow up evaluations necessary for 15 years after radiation therapy for prostate cancer patients

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Screening of children with LUT dysfunction needs refining

Greek and Spanish patients can now read EAU Patient Information in their native language

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

GCP could help lengthen life expectancy of certain prostate cancer patients

Predictive value of prostate cancer gene 3 validated

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in